These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 35255350)
41. Synthesis and biological evaluation of 4,4-dimethyl lithocholic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B. He HB; Gao LX; Deng QF; Ma WP; Tang CL; Qiu WW; Tang J; Li JY; Li J; Yang F Bioorg Med Chem Lett; 2012 Dec; 22(23):7237-42. PubMed ID: 23067554 [TBL] [Abstract][Full Text] [Related]
42. Protein tyrosine phosphatase 1B inhibitors as antidiabetic agents - A brief review. Verma M; Gupta SJ; Chaudhary A; Garg VK Bioorg Chem; 2017 Feb; 70():267-283. PubMed ID: 28043717 [TBL] [Abstract][Full Text] [Related]
43. Protein-tyrosine phosphatase 1B as a potential drug target for obesity. Dadke S; Chernoff J Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):299-304. PubMed ID: 14683461 [TBL] [Abstract][Full Text] [Related]
44. PTP1B as a drug target: recent developments in PTP1B inhibitor discovery. Zhang S; Zhang ZY Drug Discov Today; 2007 May; 12(9-10):373-81. PubMed ID: 17467573 [TBL] [Abstract][Full Text] [Related]
45. The mode of action of the Protein tyrosine phosphatase 1B inhibitor Ertiprotafib. Kumar GS; Page R; Peti W PLoS One; 2020; 15(10):e0240044. PubMed ID: 33007022 [TBL] [Abstract][Full Text] [Related]
46. Discovery of novel, high potent, ABC type PTP1B inhibitors with TCPTP selectivity and cellular activity. Liu P; Du Y; Song L; Shen J; Li Q Eur J Med Chem; 2016 Aug; 118():27-33. PubMed ID: 27123900 [TBL] [Abstract][Full Text] [Related]
47. QSAR studies of PTP1B inhibitors: recent advances and perspectives. Luan F; Xu X; Liu HT; Cordeiro MN; Zhang XY Curr Med Chem; 2012; 19(25):4208-17. PubMed ID: 22834811 [TBL] [Abstract][Full Text] [Related]
48. Dammaranes from Gynostemma pentaphyllum and synthesis of their derivatives as inhibitors of protein tyrosine phosphatase 1B. Xu JQ; Shen Q; Li J; Hu LH Bioorg Med Chem; 2010 Jun; 18(11):3934-9. PubMed ID: 20472439 [TBL] [Abstract][Full Text] [Related]
49. Discovery of novel high potent and cellular active ADC type PTP1B inhibitors with selectivity over TC-PTP via modification interacting with C site. Du Y; Zhang Y; Ling H; Li Q; Shen J Eur J Med Chem; 2018 Jan; 144():692-700. PubMed ID: 29289892 [TBL] [Abstract][Full Text] [Related]
50. Isosteviol derivatives as protein tyrosine Phosphatase-1B inhibitors: Synthesis, biological evaluation and molecular docking. Li N; Li X; Deng M; Zhu F; Wang Z; Sheng R; Wu W; Guo R Bioorg Med Chem; 2023 Apr; 83():117240. PubMed ID: 36963270 [TBL] [Abstract][Full Text] [Related]
51. The two faces of PTP1B in cancer. Lessard L; Stuible M; Tremblay ML Biochim Biophys Acta; 2010 Mar; 1804(3):613-9. PubMed ID: 19782770 [TBL] [Abstract][Full Text] [Related]
52. Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein tyrosine phosphatase 1B and augment insulin action. Bleasdale JE; Ogg D; Palazuk BJ; Jacob CS; Swanson ML; Wang XY; Thompson DP; Conradi RA; Mathews WR; Laborde AL; Stuchly CW; Heijbel A; Bergdahl K; Bannow CA; Smith CW; Svensson C; Liljebris C; Schostarez HJ; May PD; Stevens FC; Larsen SD Biochemistry; 2001 May; 40(19):5642-54. PubMed ID: 11341829 [TBL] [Abstract][Full Text] [Related]
53. Identification and characterization of potent and selective inhibitors targeting protein tyrosine phosphatase 1B (PTP1B). Jin J; Ye X; Boateng D; Dai K; Ye F; Du P; Yu H Bioorg Med Chem Lett; 2019 Aug; 29(16):2358-2363. PubMed ID: 31221555 [TBL] [Abstract][Full Text] [Related]
54. Natural products possessing protein tyrosine phosphatase 1B (PTP1B) inhibitory activity found in the last decades. Jiang CS; Liang LF; Guo YW Acta Pharmacol Sin; 2012 Oct; 33(10):1217-45. PubMed ID: 22941286 [TBL] [Abstract][Full Text] [Related]
55. α-Methyl artoflavanocoumarin from Juniperus chinensis exerts anti-diabetic effects by inhibiting PTP1B and activating the PI3K/Akt signaling pathway in insulin-resistant HepG2 cells. Jung HJ; Seong SH; Ali MY; Min BS; Jung HA; Choi JS Arch Pharm Res; 2017 Dec; 40(12):1403-1413. PubMed ID: 29177868 [TBL] [Abstract][Full Text] [Related]
56. Evaluation of 147 Kampo prescriptions as novel protein tyrosine phosphatase 1B (PTP1B) inhibitory agents. Onoda T; Li W; Higai K; Koike K BMC Complement Altern Med; 2014 Feb; 14():64. PubMed ID: 24555682 [TBL] [Abstract][Full Text] [Related]
57. Inhibition of protein tyrosine phosphatase 1B as a potential treatment of diabetes and obesity. Pei Z; Liu G; Lubben TH; Szczepankiewicz BG Curr Pharm Des; 2004; 10(28):3481-504. PubMed ID: 15579047 [TBL] [Abstract][Full Text] [Related]
58. Identification of protein tyrosine phosphatase 1B (PTP1B) inhibitors through De Novo Evoluton, synthesis, biological evaluation and molecular dynamics simulation. Wu J; Ma Y; Zhou H; Zhou L; Du S; Sun Y; Li W; Dong W; Wang R Biochem Biophys Res Commun; 2020 May; 526(1):273-280. PubMed ID: 32209254 [TBL] [Abstract][Full Text] [Related]
59. Protein Tyrosine Phosphatase 1B (PTP1B): A Comprehensive Review of Its Role in Pathogenesis of Human Diseases. Kołodziej-Sobczak D; Sobczak Ł; Łączkowski KZ Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000142 [TBL] [Abstract][Full Text] [Related]
60. Diphenylether derivative as selective inhibitor of protein tyrosine phosphatase 1B (PTP1B) over t-cell protein tyrosine phosphatase (TCPTP) identified through virtual screening. Reddy MV; Ghadiyaram C; Panigrahi SK; Hosahalli S; Mangamoori LN Mini Rev Med Chem; 2013 Oct; 13(11):1602-6. PubMed ID: 24000798 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]